Work

Metformin increases 18F-FDG flux and inhibits fatty acid oxidation at clinical doses in breast cancer: Results of a phase 0 clinical trial

Year: 2016

Type: article

Source: European Journal of Surgical Oncology

DOI: 10.1016/j.ejso.2016.07.060

Authors: Simon Lord, Dan Liu, Wei-Chen Cheng, Syed Haider, Edoardo Gaude, Eugene Teoh, Neel Patel, Tom Metcalf, Daniel McGowan, Ioannis Roxanis, Zhang Qifeng, Pankaj Roy, Fergus Gleeson, Alastair Thompson, Michael Pollak, Michael Wakelam, Francesca Buffa, Christian Frezza, John Fenwick, Adrian Harris

Institutions: University of Oxford, University of Cambridge, University of Liverpool, Babraham Institute, Oxford University Hospitals NHS Trust, McGill University

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2534042610

FWCI:

Cites:

Cited by:

Related to: 10